CTRI/2018/05/014023
Completed
Phase 2
CLINICAL EVALUATION OF THE THERAPEUTIC EFFICACY OF SARVAKALPAGHANA VATI AND TOTALA HIMA IN CHRONIC HEPATITIS B
Patanjali Ayurveda College0 sites50 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: K739- Chronic hepatitis, unspecified
- Sponsor
- Patanjali Ayurveda College
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients irrespective of sex, religion, occupation and chronicity will be selected.
- •2\. Patients with two times higher ALT levels than the upper limit of normal value will be selected.
- •3\. Patients with symptoms and signs of hepatitis B, abnormal liver functions and diagnosed cases of Chronic Hepatitis B infection will be registered.
Exclusion Criteria
- •1\. Patients aged \>65 years or \<18 years will be excluded.
- •2\. Pregnant or lactating women will be excluded.
- •3\. Patients who had hepatitis C or other hepatic viral infection, autoimmune hepatitis and drug\-induced hepatitis or alcoholic hepatitis will be excluded.
- •4\. Patients with severe complications of the cardiovascular, renal or hematopoietic systems and mental diseases will be excluded.
- •5\. Patients will be excluded having decompensated liver disease.
- •6\. Patients with prolonged or a history of ascites, developed hepato\-cellular carcinoma, hepatic encephalopathy, variceal bleeding will be excluded.
- •7\. Patients with a history of using IFN or antiviral agents or corticosteroids or immunosuppressive drugs will also be excluded.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
To evaluate the efficacy of Sarvakalpa-ghan-vati in management of non-alcoholic liver disorder.Health Condition 1: K77- Liver disorders in diseases classified elsewhereCTRI/2020/07/026362Patanjali Research Institute
Not yet recruiting
Phase 1
Role of sarvakalpa ghan vati in liver disease.Health Condition 1: K768- Other specified diseases of liverCTRI/2020/06/025733Dr Zeba Malik
Completed
Phase 2
Treatment of schizophrenia with antipsychotic drugsSchizopherenia.SchizophreniaIRCT138706051100N1Deputy of Research, Tehran University of Medical Sciences28
Completed
Not Applicable
An investigation of the clinical effectiveness of fixing the probe to the skin during ultrasound-guided central venous cannulation.Patients undergoing central venous cannulationJPRN-UMIN000009237Hirosaki University Graduate School of Medicine280
Completed
Phase 2
Evaluation of the therapeutic effects of Iranian Traditional Medicine (Hab Shabyar) in patients with open-angle glaucoma: A double-blind clinical trialopen-angle glaucoma.Primary open-angle glaucomaIRCT2016052828127N1Vice Chancellor for Research (VCR) of Tabriz University of Medical Sciences50